Stock Events

Stock Events

Cannara Biotech 

0
51
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

15JulExpected
Q1 2026
Q2 2026
0.01
0.02
0.03
0.03
Expected EPS
0.0315845775
Actual EPS
0.0315845775

Financials

12.12%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
68.4MRevenue
8.29MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8CB.STU. It's not an investment recommendation.
Microsoft
5
MSFT
Enbridge
4
ENB.TO
Royal Bank Of Canada
4
RY.TO
Apple
3
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Canopy Growth
CGC
Mkt Cap435.5M
Canopy Growth Corporation is a well-known cannabis company in Canada, directly competing in the same market as Cannara Biotech.
Aurora Cannabis
ACB
Mkt Cap167.86M
Aurora Cannabis is another major player in the Canadian and global cannabis market, offering similar products as Cannara Biotech.
Tilray Brands
TLRY
Mkt Cap545.68M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a direct competitor.
Cronos Group
CRON
Mkt Cap1.03B
Cronos Group is involved in the production and sale of cannabis in multiple countries, competing in similar segments as Cannara Biotech.
Organigram Global
OGI
Mkt Cap136.06M
Organigram Holdings focuses on the production of indoor-grown cannabis, a direct competitor in Cannara's market space.
SNDL
SNDL
Mkt Cap340.99M
Sundial Growers produces and markets cannabis for the adult-use market, directly competing with Cannara Biotech.
Village Farms International
VFF
Mkt Cap248.49M
Village Farms International leverages greenhouse-grown production techniques similar to Cannara Biotech, targeting similar markets.
Green Thumb Industries
GTBIF
Mkt Cap1.56B
Green Thumb Industries operates in the U.S. cannabis market, providing products that could compete with Cannara's offerings if laws permit cross-border competition.

About

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Show more...
CEO
Mr. Zohar Krivorot
Employees
452
Country
Canada
ISIN
CA13765U1012

Listings

STU
DE
8CB0.STU
CN
CA
LOVE.CN
STU
DE
8CB.STU
MU
DE
8CB0.MU

0 Comments

Share your thoughts

FAQ

What is Cannara Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Cannara Biotech stocks are traded under the ticker 8CB.STU.
When is the next Cannara Biotech earnings date?▼
Cannara Biotech is going to release the next earnings report on November 24, 2026.
What were Cannara Biotech earnings last quarter?▼
8CB.STU earnings for the last quarter are 0.03 EUR per share, whereas the estimation was 0.03 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Cannara Biotech revenue for the last year?▼
Cannara Biotech revenue for the last year amounts to 68.4M EUR.
What is Cannara Biotech net income for the last year?▼
8CB.STU net income for the last year is 8.29M EUR.
How many employees does Cannara Biotech have?▼
As of July 19, 2026, the company has 452 employees.
In which sector is Cannara Biotech located?▼
Cannara Biotech operates in the Health & Wellness sector.
When did Cannara Biotech complete a stock split?▼
Cannara Biotech has not had any recent stock splits.
Where is Cannara Biotech headquartered?▼
Cannara Biotech is headquartered in Saint-Laurent, Canada.